STOCK TITAN

Dexcom Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call for February 9, 2023 at 4:30 p.m. Eastern Time

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

DexCom, Inc. (NASDAQ:DXCM) announced its plans to release financial results for the fourth quarter and full year 2022 on February 9, 2023, post market close. The management will discuss the results in a conference call at 4:30 p.m. ET on the same day, which will also be available via webcast. This financial report is crucial for investors and stakeholders to gauge the company's performance in the diabetes care technology sector.

Positive
  • Upcoming financial results announcement may indicate growth potential.
  • Conference call provides an opportunity for direct communication with management.
Negative
  • None.

SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its fourth quarter and full year 2022 financial results after market close on Thursday, February 9, 2023. Management will hold a conference call to review the company's fourth quarter and full year 2022 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom investor relations website at investors.dexcom.com and will be archived there for future reference.

To listen to the conference call, please dial (888) 414-4585 (US/Canada) or (646) 960-0331 (International) and use the confirmation ID "9430114" approximately five minutes prior to the start time.

About DexCom, Inc.

DexCom, Inc. empowers people to take real-time control of diabetes through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California, and with operations across Europe and select parts of Asia/Oceania, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world. For more information about Dexcom CGM, visit www.dexcom.com.

DexCom, Inc.:

Sean Christensen

Vice President – Finance and Investor Relations

investor-relations@dexcom.com

(858) 200-0200

Source: DexCom, Inc.

FAQ

When will DexCom announce its fourth quarter 2022 results?

DexCom will announce its fourth quarter results on February 9, 2023.

What time is the DexCom conference call for the 2022 financial results?

The conference call will begin at 4:30 p.m. ET on February 9, 2023.

How can I listen to DexCom's financial results conference call?

You can listen by dialing (888) 414-4585 for US/Canada or (646) 960-0331 for international calls.

Where can I find the webcast for DexCom's financial results?

The webcast will be available on DexCom's investor relations website.

DexCom, Inc.

NASDAQ:DXCM

DXCM Rankings

DXCM Latest News

DXCM Stock Data

30.65B
389.06M
0.32%
97.12%
2.33%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
SAN DIEGO